TLR 2, 3 and 9 combinations (NCI)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTLR 2, 3 and 9 combinations (NCI)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionToll like receptor 3 modulatorsToll like receptor 2 modulatorsToll like receptor 9 modulators
TargetsToll like receptor 9Toll like receptor 3Toll like receptor 2
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A